Dealings Round-Up

Director dealings: Astrazeneca CEO raises stake

By Iain Gilbert

Date: Friday 18 Sep 2026

(Sharecast News) - Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.
Soriot, who took over as CEO in October 2012, purchased the shares at an average price of 12,102p each, for a total value of £7.26m.

As of 1540...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page